Remitting
Showing 1001 - 1020 of 1,020
Multiple Sclerosis Trial in Chapel Hill (Avonex/Zocor)
Completed
- Multiple Sclerosis
-
Chapel Hill, North CarolinaUniversity of North Carolina-Chapel Hill MS clinic within the Ne
Feb 28, 2008
HTLV-I Infection, Spinal Cord Disease, Tropical Spastic Paraparesis Trial run by the NINDS (Recombinant human interferon
Completed
- HTLV-I Infection
- +2 more
- Recombinant human interferon beta-1a
-
Bethesda, MarylandNational Institute of Neurological Disorders and Stroke (NINDS)
Mar 3, 2008
Atypical Depression Trial in New York (Duloxetine)
Completed
- Atypical Depression
-
New York, New YorkDepression Evaluation Service - New York State Psychiatric Insti
Jan 14, 2008
Mental Disorder Diagnosed in Childhood, Obsessive Compulsive Disorder, Streptococcal Infection Trial run by the NIMH (Penicillin
Completed
- Mental Disorder Diagnosed in Childhood
- +3 more
- Penicillin or Placebo
-
Bethesda, MarylandNational Institute of Mental Health (NIMH)
Mar 3, 2008
Relapsing Remitting Multiple Sclerosis, Multiple Sclerosis, Chronic Progressive Trial in Ramat Gan (Ritalin)
Unknown status
- Relapsing Remitting Multiple Sclerosis
- Multiple Sclerosis, Chronic Progressive
-
Ramat Gan, IsraelMultiple Sclerosis Center
Jan 4, 2007
Relapsing-Remitting Multiple Sclerosis Trial in Washington (Provigil (modafinil))
Unknown status
- Relapsing-Remitting Multiple Sclerosis
- Provigil (modafinil)
-
Washington, District of ColumbiaVeterans Affairs Medical Center
Sep 6, 2006
Relapsing-Remitting Multiple Sclerosis Trial in Bergen (Triomar™ (omega-3 fatty acids))
Completed
- Relapsing-Remitting Multiple Sclerosis
- Triomar™ (omega-3 fatty acids)
-
Bergen, NorwayDepartment of Neurology, Haukeland University Hospital
Aug 4, 2006
Disease-Modifying Therapy in Multiple Sclerosis
Completed
- Multiple Sclerosis
- Factors that influence compliance
-
Dallas, TexasUT Southwestern Medical Center
Jan 23, 2007
Multiple Sclerosis, Relapsing-Remitting Trial in Philadelphia (Inosine)
Completed
- Multiple Sclerosis, Relapsing-Remitting
-
Philadelphia, PennsylvaniaHospital of the University of Pennsylvania
Mar 16, 2006
Motivation in Alcohol Treatment Facilities
Completed
- Alcohol Dependence
- Alcohol Abuse
-
Greifswald, Mecklenburg-Vorpommern, Germany
- +1 more
Jan 17, 2007
All Multiple Sclerosis Patients Trial in Tel Hashomer (Provigil)
Unknown status
- All Multiple Sclerosis Patients
-
Tel Hashomer, IsraelMultiple Sclerosis Center
Feb 16, 2006
Multimodal MRI in Multiple Sclerosis: Reliability and Follow Up
Unknown status
- Multiple Sclerosis
- (no location specified)
Feb 8, 2006
Relapsing Remitting Multiple Sclerosis Trial in Birmingham (Simvastatin)
Unknown status
- Relapsing Remitting Multiple Sclerosis
-
Birmingham, AlabamaAlabama Neurology Associates
Dec 6, 2005
Multiple Sclerosis Trial in Philadelphia (Avonex and Topamax)
Unknown status
- Multiple Sclerosis
- Avonex and Topamax
-
Philadelphia, PennsylvaniaMultiple Sclerosis Institute
Sep 14, 2005
Multiple Sclerosis Trial in Gatineau (Interferon beta-1b and Tacrolimus)
Unknown status
- Multiple Sclerosis
- Interferon beta-1b and Tacrolimus
-
Gatineau, Quebec, CanadaClinique de sclérose en plaques et neuromusculaire
Mar 2, 2006
Multiple Sclerosis Trial in Rome (estroprogestins, interferon-beta 1a)
Unknown status
- Multiple Sclerosis
- estroprogestins
- interferon-beta 1a
-
Rome, ItalyDepartment of Neurology - University of Rome La Sapienza
Sep 8, 2005
Multiple Sclerosis Trial (copolymer 1)
Completed
- Multiple Sclerosis
- copolymer 1
- (no location specified)
Jun 23, 2005
Bipolar Disorder Trial in Pittsburgh (lithium carbonate, Depakote-ER, risperidone)
Completed
- Bipolar Disorder
- lithium carbonate
- +9 more
-
Pittsburgh, Pennsylvania
- +1 more
Sep 13, 2005